NANOFACTS team online meeting was held to plan not one but two more secondments at Trinity College Dublin! ESRs Mirjana Mundzić, Mila Đisalov, and Teodora Knežić are gearing up for their upcoming trips. Stay tuned for updates on their research endeavors in Dublin! We wish our ESRs the best of luck and hope they make the most of this incredible opportunity.
Dr. Nikola Knežević participated as a feature speaker at the NETPORE 2nd International Training School during July 17-20, 2023, held at the Institute of Nanoscience and Nanotechnology, National Centre for Scientific Research "Demokritos" in Athens, Greece. Dr. Knežević lectured about the novel research results in applications of mesoporous silica and organosilica nanoparticles in cancer sensing, therapy, and imaging, which was accomplished though support from the European Commission (NANOFACTS, GA. 952259) and The Science fund of the Republic of Serbia (PROMIS, PRECAST, #6060755)." Check out more here.
Our team member Mirjana Mundzic actively participated in a three-day virtual workshop titled "Designing Nanoparticles for Targeted Cancer Therapy", organized by NSTC (Nano Science & Technology Consortium) from India. The workshop covered a range of essential topics aimed at advancing the understanding of nanoparticle applications in cancer treatment. Sessions included an in-depth exploration of the fundamentals of nanoparticles, their unique properties, and their potential for targeted cancer therapy. Attendees delved into cancer biology basics to gain insights into the biology of cancer cells and its significance in crafting precise therapeutic strategies. Also, different methodologies for tailoring nanoparticles to specific cancer types and tumor microenvironments were discussed. Participants were engaged in insightful discussions on targeting mechanisms, exploring ligands and surface modifications that facilitate enhanced precision in targeting cancer cells. Nanoparticle imaging…
Dr. Nikola Knezevic participated in the 20th International NANOTEXNOLOGY Conference on Nanosciences & Nanotechnologies held in Thessaloniki, Greece. During the conference, Dr. Knežević shared exciting updates on the #NANOFACTS project, focusing on the development of #theranostic nanoparticles for the treatment and MRI imaging of Glioblastoma Multiforme.This remarkable research has tremendous potential for contribution to the field of medical science, offering innovative solutions for both therapy and non-invasive diagnostic imaging.Check out what was the presentation about in our publication section and stay tuned for more updates as Dr. Knežević and the NANOFACTS team continue to make remarkable strides in the fight against Glioblastoma Multiforme!
Thrilled to be back in Vienna for NANOFACTS research! Once again we are teaming up with the TUW group to make significant discoveries and translate them into practical solutions for the betterment of society. Stay tuned for updates on our research, as we share new findings and advancements in the field of nanotechnology.
New papers funded by Nanofacts have been published in top-tier scientific journals. Be sure to check it out as they provide insights into the latest breakthroughs in the field and offer a glimpse into the future of smart stimuli-responsive drug delivery nanosystems. We are thrilled to be supporting this important research and work. So be sure to check out these papers and the other exciting new research papers funded by NANOFACTS! You can find all the papers by clicking on this link: PUBLICATIONS
Breaking News: BioSense Unveils New Building Funded by HorizonEU Widening Grants and Advances Three Widening Projects, Including NANOFACTS! Exciting news! We are thrilled to announce the opening of the brand new BioSense building, funded by @HorizonEU widening grants. As the coordinator of one #Teaming and two #twinning projects, BioSense is at the forefront of cutting-edge research and innovation. One of these twinning projects is none other than our very own #NANOFACTS project, which aims to revolutionize the way we approach nanotechnology research. With this new building and the support from HorizonEU, we are confident that we can achieve great things and make significant contributions to the field. We would like to thank @HorizonEU for their continued support and belief in our mission. We are excited to embark on this…
In the last two years, our team completed some exciting experiments during our secondments in Dublin and Vienna, which have brought us one step closer to achieving our goal of researching cancer theranostic nanomaterials and cancer diagnostics. Through our experiments, we were able to gain new insights into the properties and behaviors of nanomaterials, which will help us to develop more effective cancer treatments and diagnostic tools. We also discovered some promising new nanomaterials that could have significant potential for cancer theranostics. Our secondments also gave us the chance to collaborate with researchers from around the world, exchanging ideas and knowledge that will help us continue to make progress in this field. It was an incredible experience that has only strengthened our commitment to advancing cancer research and treatment. Stay…
This February Dr. Nikola Knežević attended the International Meet on Pharmaceutics and Drug Delivery Systems (#Pharmameet2023) in Porto, Portugal. He delivered a keynote lecture entitled: "Cyclodextrin-Capped Mesoporous Silica-Based Nanomaterials for pH-Responsive Targeted Theranostics of Glioblastoma Multiforme".
After the summer meeting at the BioSense Institute, #nanofacts team members met last week in Vienna at the premises of the partner institution TU Wien. Seniors from Serbia and Ireland visited the Austrian partners, and reflected on the successes of the project so far while planning future postings and experiments with ESRs.